Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiPax in Low-Grade Non-Muscle Invasive Bladder Cancer
NCT03081858Phase 2Completed
- Sponsor
- LIPAC Oncology
- Start
- May 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in non-muscle-invasive bladder cancer (NMIBC), sponsored by LIPAC Oncology. Started May 2018; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT03081858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081858.